Drug intelligence / Profile preview

GMS-P11

Development stage
Preclinical
Lead developer
Gifted Molecular Science
Modality
Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

GMS-P11 is a preclinical-stage antisense oligonucleotide (ASO) candidate being developed by Gifted Molecular Science for the treatment of central nervous system (CNS) genetic disorders. The therapeutic is designed using the company's proprietary fourth-generation Druggable-PNA (peptide nucleic acid) platform technology. This platform incorporates a cationic lipid segment into the nucleobase of a metabolically stable PNA backbone, which enhances cell permeability and increases binding affinity to target mRNA sequences. GMS-P11 is intended to modulate or correct disease-associated genetic targets in the CNS, though the specific molecular target has not been publicly disclosed.

Other names
Genetic Disorder program

Beyond the preview

Go deeper on GMS-P11.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GMS-P11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call